Jilin Jian Yisheng Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 13.32%

Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has an Asset Resilience Ratio of 13.32% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥400.57 Million

≈ $58.62 Million USD Cash + Short-term Investments

Total Assets

CN¥3.01 Billion

≈ $439.90 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Jilin Jian Yisheng Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 002566 total assets.

Liquid Assets Composition Over Time

This chart breaks down Jilin Jian Yisheng Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Jilin Jian Yisheng Pharmaceutical Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥400.57 Million	13.32%
Total Liquid Assets	CN¥400.57 Million	13.32%

Asset Resilience Insights

Moderate Liquidity: Jilin Jian Yisheng Pharmaceutical Co Ltd has 13.32% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Jilin Jian Yisheng Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jilin Jian Yisheng Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Abivax SA PA:ABVX	Biotechnology	2.58%
Tubize-Fin BR:TUB	Biotechnology	2.50%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
Mineralys Therapeutics, Inc. Common Stock NASDAQ:MLYS	Biotechnology	78.33%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%
R&G PharmaStudies Co. Ltd. A SHE:301333	Biotechnology	23.94%

Annual Asset Resilience Ratio for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Jilin Jian Yisheng Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	17.15%	CN¥507.57 Million ≈ $74.27 Million	CN¥2.96 Billion ≈ $433.09 Million	+1.68pp
2024-12-31	15.47%	CN¥459.67 Million ≈ $67.26 Million	CN¥2.97 Billion ≈ $434.70 Million	+12.09pp
2023-12-31	3.38%	CN¥102.98 Million ≈ $15.07 Million	CN¥3.05 Billion ≈ $445.83 Million	+1.36pp
2022-12-31	2.02%	CN¥59.84 Million ≈ $8.76 Million	CN¥2.97 Billion ≈ $434.11 Million	-0.43pp
2021-12-31	2.45%	CN¥70.16 Million ≈ $10.27 Million	CN¥2.86 Billion ≈ $419.15 Million	+2.30pp
2017-12-31	0.15%	CN¥4.00 Million ≈ $585.33K	CN¥2.65 Billion ≈ $388.29 Million	-1.10pp
2015-12-31	1.25%	CN¥33.00 Million ≈ $4.83 Million	CN¥2.63 Billion ≈ $385.40 Million	-2.04pp
2014-12-31	3.29%	CN¥82.00 Million ≈ $12.00 Million	CN¥2.49 Billion ≈ $364.42 Million	+3.21pp
2006-12-31	0.08%	CN¥269.00K ≈ $39.36K	CN¥338.04 Million ≈ $49.47 Million	--

pp = percentage points

About Jilin Jian Yisheng Pharmaceutical Co Ltd

SHE:002566 China Biotechnology

Market Cap

$339.48 Million

CN¥2.32 Billion CNY

Market Cap Rank

#14306 Global

#4296 in China

Share Price

CN¥7.01

Change (1 day)

+0.72%

52-Week Range

CN¥5.82 - CN¥9.05

All Time High

CN¥19.38